Obesity, for example, is rare in a state of nature.

例如肥胖症在极少数情况下是天生的。

Listen out for when the word, obesity, started to be used.

请听“肥胖症”这个词是什么时候开始使用的。

Obesity among children and young people is on course to increase faster than among adults.

儿童和青年群体中肥胖症患者增速比成年人更快。

This increase your risk for obesity and developing type 2 diabetes.

这增加了你患肥胖症和2型糖尿病的风险。

But those advisories had been centered on the increased risks of heart disease and obesity.

只是这些健康警告围绕的主题一直是心脏病和肥胖症。

Claudia believes anyone can have an impact on reducing childhood obesity.

克劳迪娅认为，所有人都能够为儿童肥胖症出力。

And he lives with obesity because he's been harming himself by overeating.

他的生活受肥胖症困扰，因为他一直在用暴饮暴食伤害自己。

Insufficient sleep contributes to the risk of cardiovascular disease, diabetes and obesity.

睡眠不足会引发心血管疾病、糖尿病及肥胖症病发风险。

Wegovy was approved in 2021 to treat obesity in adults and children older than 11.

Wegovy于2021年被批准用于治疗成人和11岁以上儿童的肥胖症。

Why not? Just because his great-grandmother was obese?

为什么呢？ 就只因为他曾祖母有肥胖症吗？

He says that individuals who are effortlessly trim may hold the key to understanding obesity.

他表示，轻松保持苗条身材的人可能掌握着了解肥胖症的关键。

Poor sleep is associated with high blood pressure, obesity, diabetes and other illnesses as well.

睡眠不足会引发高血压 肥胖症 糖尿病以及其他各种各样的疾病。

All right, now for my presentation: Obesity in America.

好了，这就是我的演讲：美国的肥胖症。

That report estimated around 774 million people above the age of five were living with obesity.

该报告估计，大约有7.74亿5岁以上的人患有肥胖症。

49. What did Dr. Rao find after 20 years of research on obesity?

问题 49.饶博士对肥胖症进行了 20 年的研究，发现了什么？

The users were also 81 percent less likely to become obese over the time scale surveyed.

使用公共交通工具的人们患上肥胖症的几率降低了81%。

The largest country in the Arabian Peninsula, 35.2% of Saudi Arabia's population struggles with obesity.

阿拉伯半岛上最大的国家，35.2%的沙特阿拉伯人患有肥胖症。

For both Saxenda and Wegovy, there is a lack of long-term safety and effectiveness data for obesity.

Saxenda和Wegovy都缺乏治疗肥胖症的长期安全性和有效性数据。

It is approved for diabetes treatment and the FDA is considering it for obesity.

它被批准用于治疗糖尿病，美国食品药品监督管理局正在考虑将其用于治疗肥胖症。

The risk increases with the number of underlying health conditions, such as obesity or high blood pressure.

这些风险因肥胖症和高血压等潜在健康状况数字增加而上升。